Abstract
In a number of patients with congenital Hemophilia A the treatment is complicated by the presence of factor VIII inhibitors. These are alloantibodies which the patients only develop after receiving replacement therapy with factor VIII preparations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gilles JGG, Jacquemin MG, Saint Remy JMR. Factor VIII inhibitors. Thromb Haemost 1997; 78: 641–646
Green D. Acquired factor VIII inhibitors and immunosuppression of autoantibodies. In: Kessler C, Garvey MB, Green D, Kasper C, Lusher J (eds). Acquired hemophilia. Excerpta Medica Princetown 1995; 25–40
Green D, Blanc J, Foiles N. Spontaneous inhibitors of factor VIII: kinetics of inactivation of human and porcine factor VIII. J Lab Clin Med 1999; 133: 260–264
Hay CR. Porcine factor VIII: past, present and future. Haematologica 2000; 85(10 Suppl): 21–24
Hay CRM, Baglin TP, Collins PW, Hill FGH, Keeling DM. The diagnosis and Management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctor’s Organization (UKHCDO). Brit J Haematol 2000; 111: 78–90
Hoyer LW. Inhibitors in hemophilia. In: Forbes CD, Aledort L, Madhok R (eds). Hemophilia. Chapman Hall London 1997; 213–227
Huhmann I, Lechner K. Spontane Faktor Vlll-Inhibitoren. Hämostaseologie 1996; 16: 164–170
Kasper CK. Laboratory diagnosis of factor VIII inhibitors. In: Kessler C, Garvey MB, Green D, Kasper C, Lusher J (eds). Acquired hemophilia. Excerpta Medica Princetown 1995; 9–23
Kessler CM. The treatment of acquired factor VIII inhibitors: Worldwide experience with porcine factor VIII. In: Kessler C, Garvey MB, Green D, Kasper C, Lusher J (eds). Acquired hemophilia. Excerpta Medica Princetown 1995; 71–89
Lechner K. Antikörperbildung — die derzeit gravierendste Komplikation der Substitutionstherapie bei Hämophilie. In: Scharrer I, Schramm W (eds). 26. Hämophilie-Symposion Hamburg 1995. Springer Berlin Heidelberg 1997; 61–67
Lutze G, Kutschmann K, Thomae K, Lutze GJR, Franke D. Erfolgreicher therapeutischer Einsatz von porcinem Faktor VIII bei der Hämophilie A des Hundes. Prakt Tierarzt 1999; 80: 664–670
Lutze GJR. Untersuchungen zur Wirkung von Gerinnungsfaktor Vlll-Inhibitoren bei angeborenem und erworbenem Faktor VIII-Mangel (Hemmkörperhämophilie A und spontane Hämophilie A) auf tierischen Faktor VIII. Otto-von-Guericke-Universität Magdeburg 2000; Inauguraldissertation
Meili EO, Von Feiten A. Bestimmt die Art der Blutstillung den klinischen Verlauf bei Patienten Mit erworbener Hemmkörperhämophilie? In: Scharrer I, Schramm W (eds). 27. Hämophilie-Symposion Hamburg 1996. Springer Berlin Heidelberg 1998; 89–91
Moliterno A, Bell WR. Acquired coagulation inhibitors in the non-congenital factor deficient population: Clinical Manifestations and Management. In: Scharrer I, Schramm W (eds). 27. Hämophilie-Symposion Hamburg 1996. Springer Berlin Heidelberg 1998; 67–75
Scharrer I. Acquired inhibitors against factor VIII and factor IX. In: Hach-Wunderle V, Nawroth PP (eds). Life-threatening coagulation disorders in critical care Medicine. Springer Berlin Heidelberg 1997; 51–59
Shapiro SS, Rajagopalan V. Hemorrhagic disorders associated with circulating inhibitors. In: Ratnoff OD, Forbes CD (eds). Disorders of hemostasis. W.B. Saunders Philadelphia London 1996; 208–227
Tuddenham EGD, McVey JH. The genetic basis of inhibitor development in haemophilia A. Haemophilia 1998; 4: 543–545
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Aumann, V., Lutze, G., Lutze, G., Franke, D., Mittler, U. (2003). Inactivation of Animal Factor VIII by human Factor VIII Inhibitors: Investigation of Plasma from Patients with Inhibitors in congenital Hemophilia A and from Patients with acquired Hemophilia A. In: Scharrer, I., Schramm, W. (eds) 32nd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18150-4_43
Download citation
DOI: https://doi.org/10.1007/978-3-642-18150-4_43
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-43884-7
Online ISBN: 978-3-642-18150-4
eBook Packages: Springer Book Archive